Cargando…

Origins Matter: Culture Impacts Cognitive Testing in Parkinson’s Disease

Cognitive decline is common in Parkinson’s disease (PD), and precise cognitive assessment is important for diagnosis, prognosis, and treatment. To date, there are no studies in PD investigating cultural bias on neuropsychological tests. Clinical practice in multicultural societies such as, Toronto C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Statucka, Marta, Cohn, Melanie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694800/ https://www.ncbi.nlm.nih.gov/pubmed/31440150 http://dx.doi.org/10.3389/fnhum.2019.00269

Ejemplares similares

White-Matter Changes Correlate with Cognitive Functioning in Parkinson’s Disease
por: Theilmann, Rebecca J., et al.
Publicado: (2013)

Distinct Relationship Between Cognitive Flexibility and White Matter Integrity in Individuals at Risk of Parkinson’s Disease
por: Alzaid, Haidar, et al.
Publicado: (2020)

Gray/White Matter Contrast in Parkinson’s Disease
por: Uribe, Carme, et al.
Publicado: (2018)

Incidence of Mild Cognitive Impairment and Dementia in Parkinson’s Disease: The Parkinson’s Disease Cognitive Impairment Study
por: Nicoletti, Alessandra, et al.
Publicado: (2019)

Associations among Cognitive Functions, Plasma DNA, and White Matter Integrity in Patients with Early-Onset Parkinson's Disease
por: Chen, Yueh-Sheng, et al.
Publicado: (2017)

Validation of the European Cross-Cultural Neuropsychological Test Battery (CNTB) for the assessment of mild cognitive impairment due to Alzheimer's disease and Parkinson's disease
por: Delgado-Álvarez, Alfonso, et al.
Publicado: (2023)

Clinical and cognitive correlates tractography analysis in patients with white matter hyperintensity of vascular origin
por: Kuang, Qinmei, et al.
Publicado: (2023)

Cognitive and Behavioral Inhibition Deficits in Parkinson’s Disease: The Hayling Test as a Reliable Marker
por: Siquier, Antònia, et al.
Publicado: (2021)

Computerized Dual-Task Testing of Gait Visuomotor and Cognitive Functions in Parkinson’s Disease: Test-Retest Reliability and Validity
por: Bhatt, Mayank, et al.
Publicado: (2021)

Cognitive Impact of Deep Brain Stimulation in Parkinson’s Disease Patients: A Systematic Review
por: Rački, Valentino, et al.
Publicado: (2022)

Impact of Parkinson’s Disease on Functional Mobility at Different Stages
por: Mollà-Casanova, Sara, et al.
Publicado: (2022)

Retinal Degeneration: A Window to Understand the Origin and Progression of Parkinson’s Disease?
por: Zhang, Yanyan, et al.
Publicado: (2022)

Original research: initial development of a pragmatic tool to estimate cognitive decline risk focusing on potentially modifiable factors in Parkinson’s disease
por: Carlisle, Tara C., et al.
Publicado: (2023)

Poorer Cognitive Performance in Patients with Essential Tremor-Parkinson’s Disease vs. Patients with Parkinson’s Disease
por: Louis, Elan D., et al.
Publicado: (2015)

Fronto-striatal gray matter contributions to discrimination learning in Parkinson's disease
por: O'Callaghan, Claire, et al.
Publicado: (2013)

Original research: longitudinal evaluation of cognitively demanding daily function using performance-based functional assessment highlights heterogeneous trajectories in cognitive and functional abilities in people with Parkinson’s disease
por: Carlisle, Tara C., et al.
Publicado: (2023)

Precuneus Dysfunction in Parkinson’s Disease With Mild Cognitive Impairment
por: Jia, Xiuqin, et al.
Publicado: (2019)

The emerging role of norepinephrine in cognitive dysfunctions of Parkinson's disease
por: Vazey, Elena M., et al.
Publicado: (2012)

Immersive Technology for Cognitive-Motor Training in Parkinson’s Disease
por: Lau, Justin, et al.
Publicado: (2022)

KTN1 Variants Underlying Putamen Gray Matter Volumes and Parkinson’s Disease
por: Mao, Qiao, et al.
Publicado: (2020)

Outer Retinal Layer Thickness Changes in White Matter Hyperintensity and Parkinson's Disease
por: Zhao, Yitian, et al.
Publicado: (2021)

Aberrant gray matter volume and functional connectivity in Parkinson’s disease with minor hallucination
por: Zhong, Min, et al.
Publicado: (2022)

Subjective Cognitive Complaints in Newly-Diagnosed Parkinson’s Disease With and Without Mild Cognitive Impairment
por: Pan, Chenxi, et al.
Publicado: (2021)

How Cognition and Motivation “Freeze” the Motor Behavior in Parkinson’s Disease
por: Ortelli, Paola, et al.
Publicado: (2019)

Rational Pharmacological Approaches for Cognitive Dysfunction and Depression in Parkinson’s Disease
por: Sandoval-Rincón, Maritza, et al.
Publicado: (2015)

Neuroimaging studies of striatum in cognition part II: Parkinson's disease
por: Hanganu, Alexandru, et al.
Publicado: (2015)

Does Cognitive Impairment Affect Rehabilitation Outcome in Parkinson’s Disease?
por: Ferrazzoli, Davide, et al.
Publicado: (2016)

Cognitive, Emotional, and Auto-Activation Dimensions of Apathy in Parkinson's Disease
por: Del-Monte, Jonathan, et al.
Publicado: (2017)

Aberrant Intrinsic Activity and Connectivity in Cognitively Normal Parkinson’s Disease
por: Harrington, Deborah L., et al.
Publicado: (2017)

Determinants of Quality of Life According to Cognitive Status in Parkinson’s Disease
por: Fan, Yun, et al.
Publicado: (2020)

Natural Reading in Parkinson’s Disease With and Without Mild Cognitive Impairment
por: Stock, Lena, et al.
Publicado: (2020)

Quantitative Electroencephalography as a Biomarker for Cognitive Dysfunction in Parkinson’s Disease
por: Novak, Kevin, et al.
Publicado: (2022)

Does Prefrontal Glutamate Index Cognitive Changes in Parkinson’s Disease?
por: Buard, Isabelle, et al.
Publicado: (2022)

Aquaporin-4 Polymorphisms Are Associated With Cognitive Performance in Parkinson’s Disease
por: Fang, Yi, et al.
Publicado: (2022)

Ophthalmologic problems correlates with cognitive impairment in patients with Parkinson's disease
por: Zhang, Chao, et al.
Publicado: (2022)

Subjective cognitive decline in patients with Parkinson’s disease: an updated review
por: Huang, Juan, et al.
Publicado: (2023)

Optimizing Cognitive Training for the Treatment of Cognitive Dysfunction in Parkinson’s Disease: Current Limitations and Future Directions
por: Guglietti, Bianca, et al.
Publicado: (2021)

Associations Between Cognitive Functions and Physical Frailty in Patients With Parkinson’s Disease
por: Lin, Wei-Che, et al.
Publicado: (2019)

Predicting Cognitive Decline in Parkinson’s Disease: Can We Ask the Genes?
por: De Marchi, Fabiola, et al.
Publicado: (2014)

Pupillary Response to Cognitive Demand in Parkinson’s Disease: A Pilot Study
por: Kahya, Melike, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_efdemeost186d9k80mc82bdqb6